Current Status of β-Thalassemic Burden in India

References

• Weatherall DJ, Clegg JB. Thalassemia—a global public health problem. Nat Med. 1996;2(8):847–849. doi: 10.1038/nm0896-847.
   PubMed Web of Science ®Google Scholar
• Ou Z, Li Q, Liu W, et al. Elevated hemoglobin A2 as a marker for beta-thalassemia trait in pregnant women. Tohoku J Exp Med. 2011;223(3):223–226. doi: 10.1620/tjem.223.223.
   PubMed Web of Science ®Google Scholar
• Marengo-Rowe AJ. Structure-function relations of human hemoglobins. Proc (Bayl Univ Med Cent). 2006;19(3):239–245. doi: 10.1080/08998280.2006.11928171.
   PubMedGoogle Scholar
• Balgir RS. The burden of haemoglobinopathies in India and the challenges ahead. Curr Sci. 2000;79(11):1536–1547.
   Web of Science ®Google Scholar
• Higgs DR. The molecular basis of alpha-thalassemia. Cold Spring Harb Perspect Med. 2013;3(1):a011718. doi: 10.1101/cshperspect.a011718.
   PubMed Web of Science ®Google Scholar
• Muncie HL Jr, Campbell J. Alpha and beta thalassemia. Am Fam Physician. 2009;80(4):339–344.
   PubMed Web of Science ®Google Scholar
• Rund D, Rachmilewitz E. Beta-thalassemia. N Engl J Med. 2005;353(11):1135–1146. doi: 10.1056/NEJMra050436.
   PubMed Web of Science ®Google Scholar
• Hassan TB, El Safy U, Hesham M, et al. β-Thalassemia: genotypes and phenotypes [Internet]. In: Kasenga FH, editor. Epidemiology of communicable and non-communicable diseases—attributes of lifestyle and nature on humankind. IntechOpen; 2016.
   Google Scholar
• Romao L, Inacio A, Santos S, et al. Nonsense mutations in the human beta-globin gene lead to unexpected levels of cytoplasmic mRNA accumulation. Blood. 2000;96(8):2895–2901.
   PubMed Web of Science ®Google Scholar
• Ho PJ, Sloane-Stanley J, Athanassiadou A, et al. An in vitro system for expression analysis of mutations of the beta-globin gene: validation and application to two mutations in the 5' UTR. Br J Haematol. 1999;106(4):938–947. doi: 10.1046/j.1365-2141.1999.01659.x.
   PubMed Web of Science ®Google Scholar
• Cárdenas EMB. Bioinformatic analysis of insertion, deletion, and substitution mutations in the human β-globin gene. Comput Mol Biosci. 2021;11(01):1–17. doi: 10.4236/cmb.2021.111001.
   Google Scholar
• Ali S, Mumtaz S, Shakir HA, et al. Current status of beta-thalassemia and its treatment strategies. Mol Genet Genomic Med. 2021;9(12):e1788. doi: 10.1002/mgg3.1788.
   PubMed Web of Science ®Google Scholar
• Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5(1):11. doi: 10.1186/1750-1172-5-11.
   PubMed Web of Science ®Google Scholar
• Marengo-Rowe AJ. The thalassemias and related disorders. Proc (Bayl Univ Med Cent). 2007;20(1):27–31. doi: 10.1080/08998280.2007.11928230.
   PubMedGoogle Scholar
• Olivieri NF, Pakbaz Z, Vichinsky E. Hb E/beta-thalassaemia: a common & clinically diverse disorder. Indian J Med Res. 2011;134(4):522–531. PubMed PMID: 22089616; PubMed Central PMCID: PMCPMC3237252.
   PubMedGoogle Scholar
• Nuinoon M, Kruachan K, Sengking W, et al. Thalassemia and hemoglobin E in southern Thai blood donors. Adv Hematol. 2014;2014:932306. doi: 10.1155/2014/932306.
   PubMedGoogle Scholar
• WHO South-East Asia. Regional desk review of haemoglobinopathies with an emphasis on thalassaemia and accessibility and availability of safe blood and blood products as per these patients’ requirement in South-East Asia under universal health coverage. New Delhi; 2021. ISBN: 978-92-9022-851-6.
   Google Scholar
• Angastiniotis M, Vives Corrons JL, Soteriades ES, et al. The impact of migrations on the health services for rare diseases in Europe: the example of haemoglobin disorders. ScientificWorldJournal. 2013;2013:727905–727910. doi: 10.1155/2013/727905.
   PubMed Web of Science ®Google Scholar
• Sayani FA, Kwiatkowski JL. Increasing prevalence of thalassemia in America: implications for primary care. Ann Med. 2015;47(7):592–604. doi: 10.3109/07853890.2015.1091942.
   PubMed Web of Science ®Google Scholar
• Kattamis A, Forni GL, Aydinok Y, et al. Changing patterns in the epidemiology of beta-thalassemia. Eur J Haematol. 2020;105(6):692–703. doi: 10.1111/ejh.13512.
   PubMed Web of Science ®Google Scholar
• Cataldo F. Immigration and changes in the epidemiology of hemoglobin disorders in Italy: an emerging public health burden. Ital J Pediatr. 2012;38(1):32. doi: 10.1186/1824-7288-38-32.
   PubMed Web of Science ®Google Scholar
• Baird DC, Batten SH, Sparks SK. Alpha- and beta-thalassemia: rapid evidence review. Am Fam Physician. 2022;105(3):272–280.
   PubMedGoogle Scholar
• Colah R, Italia K, Gorakshakar A. Burden of thalassemia in India: the road map for control. Pediatr Hematol Oncol J. 2017;2(4):79–84. doi: 10.1016/j.phoj.2017.10.002.
   Google Scholar
• National Health Mission. NHM guidelines on prevention and control of hemoglobinopathies in India - Thalassemias, sickle cell diseases and other varient hemoglobins. New Delhi (India): Ministry of Health and Family Welfare, Government of India; 2016. p. 1–138.
   Google Scholar
• Jawahirani A, Mamtani M, Das K, et al. Prevalence of beta-thalassemia in subcastes of Indian Sindhis: results from a two-phase survey. Public Health. 2007;121(3):193–198. doi: 10.1016/j.puhe.2006.10.017.
   PubMed Web of Science ®Google Scholar
• Madan N, Sharma S, Sood SK, et al. Frequency of beta-thalassemia trait and other hemoglobinopathies in northern and western India. Indian J Hum Genet. 2010;16(1):16–25. doi: 10.4103/0971-6866.64941.
   PubMedGoogle Scholar
• Patel AG, Shah AP, Sorathiya SM, et al. Hemoglobinopathies in south Gujarat population and incidence of anemia in them. Indian J Hum Genet. 2012;18(3):294–298. doi: 10.4103/0971-6866.107979.
   PubMedGoogle Scholar
• Mohanty D, Colah RB, Gorakshakar AC, et al. Prevalence of beta-thalassemia and other haemoglobinopathies in six cities in India: a multicenter study. J Community Genet. 2013;4(1):33–42. doi: 10.1007/s12687-012-0114-0.
   PubMedGoogle Scholar
• Mondal S, Mondal S, Das N, et al. Spectrum of thalassemias and hemoglobinopathies in West Bengal: a study of 90,210 cases by cation exchange high-performance liquid chromatography method over a period of 8 years. J Appl Hematol. 2014;5(3):91–95. doi: 10.4103/1658-5127.141993.
   Google Scholar
• Shanthi G, Balsubramanyam D, Srinivasan R. Clinical and demographical studies of Beta-thalassemia in Tamilnadu. Res J Pharm Biol Chem Sci. 2013;4(3):952–956.
   Google Scholar
• Krishnamurthy BN, Niveditha SR, Shankar P. Frequency of Beta thalassemia trait in pediatric age group in a tertiary care hospital in south India. Ann Appl Biosci. 2016;3(2):A143–A150.
   Google Scholar
• Yadav SS, Panchal P, Menon KC. Prevalence and management of beta-thalassemia in India. Hemoglobin. 2022;46(1):27–32. doi: 10.1080/03630269.2021.2001346.
   PubMed Web of Science ®Google Scholar
• Dolai TK, Dutta S, Bhattacharyya M, et al. Prevalence of hemoglobinopathies in rural Bengal, India. Hemoglobin. 2012;36(1):57–63. doi: 10.3109/03630269.2011.621007.
   PubMed Web of Science ®Google Scholar
• Saha S, Ghosh S, Basu K, et al. Prevalence of β-haemoglobinopathies in eastern India and development of a novel formula for carrier detection. J Hematopathol. 2020;13(3):159–164. doi: 10.1007/s12308-020-00407-7.
   Web of Science ®Google Scholar
• Meher S, Patel DK, Patel S, et al. Epidemiology of beta thalassemia trait in eastern India. Odisha Phys J. 2012;9:24–29.
   Google Scholar
• Thakur A, Jha SC, Mishra PK, et al. Beta thalassemia and its variant: a clinicopathological correlation of 100 cases in Bihar, India. Int J Biomed Adv Res. 2019;10(2):e5085–92.
   Google Scholar
• Tirkey D, Mahto S. Prevalence of thalassemia in tribal patients attending tertiary care hospital in Jharkhand. Int J Sci Res. 2018;7(7):28–29.
   Google Scholar
• Tete A, Kumari K, Devraj D, et al. Hemoglobinopathies contributing to anemia: a tertiary care center study from Jharkhand. J Med Dent Sci Res. 2022;9(1):20–22.
   Google Scholar
• Prasad C, Singh SB, Mahato T, et al. An Assessment of the genetic load of hemoglobinopathies by using retention time chromatogram: a tertiary care hospital based study, located In Ranchi district of Jharkhand. Res J Pharm Biol Chem Sci. 2014;5(1):1088–1101.
   Google Scholar
• Talsania S, Talsania N, Nayak H. A cross sectional study of thalassemia in Ahmedabad city, Gujarat. Healthline. 2011;2(1):48–51.
   Google Scholar
• Ashwin P, Madhuben N, Nilam S, et al. Prevalence of common hemoglobinopathies in Gujarat: an analysis of a large population screening programme. Natl J Community Med. 2012;3(1):112–116.
   Google Scholar
• Vachhani NA, Vekariya DJ, Colah RB, et al. Spectrum of beta-thalassemia and other hemoglobinopathies in the Saurashtra region of Gujarat, India: analysis of a large population screening program. Hemoglobin. 2022;46(5):285–289. doi: 10.1080/03630269.2022.2142608.
   PubMed Web of Science ®Google Scholar
• Amran Z, Thakkar M, Mhera M. Prevalence of beta-thalassemia trait and sickle cell trait in-Gujarat-India. Int J Creat Res Thoughts. 2018;6(2):996–1000.
   Google Scholar
• Bhanvadia VM, Chavda A, Mehta D, et al. Study of prevalence of hemoglobinopathy in Sindhi community of Jamnagar, Gujarat: a pilot study. Int J Med Public Health. 2015;5(4):349–352. doi: 10.4103/2230-8598.165091.
   Google Scholar
• Satpute S, Bankar M, Abdulrahaman A, et al. The incidence of B thalassemia trait in pregnant women from south western Maharashtra. Int J Health Sci Res. 2012;2(1):103–107.
   Google Scholar
• Chalke A, Nengi R, Karde B, et al. Prevalence of thalassemia in and around Mumbai district Maharashtra. J Contemp Med Dent. 2022;10(2):25–27.
   Google Scholar
• Rakholia R, Chaturvedi P. Prevalence of β thalassemia carrier state in Sindhi community of Wardha and evaluation of risk factors for β thalassemia trait. Niger J Clin Pract. 2013;16(3):375–380. doi: 10.4103/1119-3077.113468.
   PubMed Web of Science ®Google Scholar
• Kalpana B, Rathod D, Hashmi Z, et al. Prevalence of thalassemia in and around Pune District, Maharashtra. Int J Healthc Biomed Res. 2017;5(2):28–31.
   Google Scholar
• Munj VS, Dias M, Gomes N. A retrospective laboratory study of the spectrum of hemoglobin disorders in North Goa District Hospital. J Med Sci Clin Res. 2019;7(10):262–267. doi: 10.18535/jmscr/v7i10.45.
   Google Scholar
• Chatterjee N, Mishra A, Soni R, et al. Bayesian estimates of the prevalence of beta-thalassemia trait in voluntary blood donors of central India: a survey. Hemoglobin. 2010;34(6):548–560. doi: 10.3109/03630269.2010.526488.
   PubMed Web of Science ®Google Scholar
• Gangwani A, Shah M. Hematological study of iron deficiency anemia and β thalassemia trait in Sindhi community of Bundelkhand region of Madhya Pradesh with predictive value of red cell indices to discriminate them. Trop J Pathol Microbiol. 2019;5(7):449–453. doi: 10.17511/jopm.2019.i07.06.
   Google Scholar
• Baxi A, Manila K, Kadhi P, et al. Carrier screening for β thalassemia in pregnant Indian women: experience at a single center in Madhya Pradesh. Indian J Hematol Blood Transfus. 2013;29(2):71–74. doi: 10.1007/s12288-012-0165-8.
   PubMed Web of Science ®Google Scholar
• Tomar A, Chouhan RPS. Clinico-hematological profile of hemolytic anemia at the SAMS Medical College Hospital. Indian J Pathol Oncol. 2021;8(2):283–286. doi: 10.18231/j.ijpo.2021.055.
   Google Scholar
• Balgir RS. Inherited hemolytic disorders with high occurrence of ß-thalassemia in Sindhi community of Jabalpur town in Madhya Pradesh, India. Online J Health Allied Sci. 2009;8(4):1–4.
   Google Scholar
• Pande PL, Singh M, Choudhary NK. Occurrence of β-thalassemia among the Sindhi Community of Jabalpur, Madhya Pradesh (Central India). J Hum Ecol. 2005;17(2):157–158. doi: 10.1080/09709274.2005.11905772.
   Google Scholar
• Thakur S, Sharma R, Raw SN. Incidence of thalassemia and sickle cell disease in Chhattisgarh, Central India: using Hardy-Weinberg equations. Mol Genet Med. 2015;9(1):1–5.
   Google Scholar
• Mathew A, Sobti P. The burden of thalassemia in Punjab: a roadmap forward. Pediatr Hematol Oncol J. 2017;2(4):85–87. doi: 10.1016/j.phoj.2018.01.001.
   Google Scholar
• Nigam N, Kushwaha R, Yadav G, et al. A demographic prevalence of beta Thalassemia carrier and other hemoglobinopathies in adolescent of Tharu population. J Family Med Prim Care. 2020;9(8):4305–4310. doi: 10.4103/jfmpc.jfmpc_879_20.
   PubMedGoogle Scholar
• Meena LP, Kumar K, Singh VK, et al. Study of mutations in beta-thalassemia trait among blood donors in eastern Uttar Pradesh. J Clin Diagn Res. 2013;7(7):1394–1396. doi: 10.7860/JCDR/2013/5456.3150.
   PubMedGoogle Scholar
• Kumar R, Gupta S, Jindal A, et al. Screening of β-thalassemia trait and other hemoglobinopathies among blood donors in Punjab. Int J Med Public Health. 2015;5(1):106–109. doi: 10.4103/2230-8598.151273.
   Google Scholar
• Narang V, Grover S, Soni A, et al. Prevalence and spectrum of haemoglobinopathies in females of reproductive age group—a first tertiary care center experience in Punjab, North India. Indian J Pathol Microbiol. 2023;66(3):564–567.
   Web of Science ®Google Scholar
• Bharti OK, Sood RK, Sharma HR, et al. Mean corpuscular volume/mean corpuscular hemoglobin values are not reliable predictors of the beta-thalassemia carrier status among healthy diverse populations of Himachal Pradesh, India. Asian J Transfus Sci. 2020;14(2):172–178. doi: 10.4103/ajts.AJTS_109_18.
   PubMed Web of Science ®Google Scholar
• Mohanty SS, Parihar S, Huda RK, et al. Prevalence of sickle cell anemia, β-thalassemia and glucose-6-phosphate dehydrogenase deficiency among the tribal population residing in the Aravali hills of Sirohi region of Rajasthan state. Clin Epidemiol Glob Health. 2022;13:100916. doi: 10.1016/j.cegh.2021.100916.
   Web of Science ®Google Scholar
• Mishra A, Lakhera P. Prevalence of beta thalassemia trait in the population of Garhwal (Uttarakhand): an alarming call for the Himalayan region. Asian Man. 2017;11(2):196. doi: 10.5958/0975-6884.2017.00033.0.
   Google Scholar
• Singh N, Chowdhury N, Bahadur A, et al. Thalassemia and hemoglobinopathy screening in women attending antenatal clinic at a tertiary care center in Uttarakhand, India: a re-look at the laboratory parameters mandating high-performance liquid chromatography workup. Cureus. 2023;15(6):e40667. doi: 10.7759/cureus.40667.
   PubMed Web of Science ®Google Scholar
• Jandial R, Gupta I. Incidence of thalassemia in Jammu and Kashmir, India. Natil J Lab Med. 2021;10(1):P011–P013.
   Google Scholar
• Das R, Datta S, Kaviraj A, et al. A decision support scheme for beta thalassemia and HbE carrier screening. J Adv Res. 2020;24:183–190. doi: 10.1016/j.jare.2020.04.005.
   PubMed Web of Science ®Google Scholar
• Munshi A, Anandraj MP, Joseph J, et al. Inherited hemoglobin disorders in Andhra Pradesh, India: a population study. Clin Chim Acta. 2009;400(1–2):117–119. doi: 10.1016/j.cca.2008.10.025.
   PubMed Web of Science ®Google Scholar
• Haritha P, Laxmi V, Veerraju P, et al. Prevalence of hemoglobinopathies among the Konda Kammaras of Visakhapatnam district, Andhra Pradesh. IOSR J Pharm Biol Sci. 2012;2(4):6–8. doi: 10.9790/3008-0240608.
   Google Scholar
• Gunda P, Kondaveeti S, Manne M, et al. Prevalence of thalassemia and sickle cell anemia carriers among antenatal women—a first study from Telangana population. Indian J Obstetr Gynecol Res. 2022;10(1):32–35.
   Google Scholar
• Ajmera S, Banoth B, Ramkishan R, et al. Prevalence of sickle cell anemia and thalassemia in tribal lambda community in Warangal district. J Evol Med Dent Sci. 2017;6(36):2953–2956. doi: 10.14260/Jemds/2017/636.
   Google Scholar
• Kulkarni P, Masthi NR, Niveditha S, et al. The prevalence of the beta thalassemia trait among the pregnant women who attended the ANC clinic in a PHC, by using the NESTROF test in Bangalore, Karnataka. J Clin Diagn Res. 2013;7(7):1414–1417. doi: 10.7860/JCDR/2013/5286.3149.
   PubMedGoogle Scholar
• Devi M. Prevalence of beta thalassemia trait among antenatal women attending a tertiary care center [master’s thesis]. Chennai (India): Stanley Medical College; 2020.
   Google Scholar
• Bhuvana S, Swaminathan R. Studies on beta thalassemia and other hemoglobinopathiesin metropolitan city of Chennai, Tamil Nadu, India. Int J Biol Sci. 2016;7(1):7–19.
   Google Scholar
• Sinha S, Black ML, Agarwal S, et al. Profiling beta-thalassaemia mutations in India at state and regional levels: implications for genetic education, screening and counselling programmes. Hugo J. 2009;3(1–4):51–62. doi: 10.1007/s11568-010-9132-3.
   PubMedGoogle Scholar
• Sanchez-Villalobos M, Blanquer M, Moraleda JM, et al. New insights into pathophysiology of beta-thalassemia. Front Med. 2022;9:880752. doi: 10.3389/fmed.2022.880752.
   Web of Science ®Google Scholar
• Wu H, Wang H, Lan L, et al. Invasive molecular prenatal diagnosis of alpha and beta thalassemia among Hakka pregnant women. Medicine. 2018;97(52):e13557. doi: 10.1097/MD.0000000000013557.
   PubMed Web of Science ®Google Scholar
• Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harb Perspect Med. 2013;3(2):a011775. doi: 10.1101/cshperspect.a011775.
   PubMed Web of Science ®Google Scholar
• Colah RB, Gorakshakar A. Control of thalassemia in India. Thal Rep. 2014;4(s1):1955. doi: 10.4081/thal.2014.s1.1955.
   Google Scholar
• Orofino MG, Argiolu F, Sanna MA, et al. Fetal HLA typing in beta thalassaemia: implications for haemopoietic stem-cell transplantation. Lancet. 2003;362(9377):41–42. doi: 10.1016/S0140-6736(03)13806-8.
   PubMed Web of Science ®Google Scholar
• Kushwaha D. Correlation between RBC indices, Mentzer index and HPLC findings in patients of anemia. Int J Curr Res. 2019;11(7):5232–5235.
   Google Scholar
• Nandi A, Talukdar M, Bhattacharya S, et al. Red blood cell indices in different hemoglobinopathies: a cross-sectional study in eastern India. Indian J Pathol Microbiol. 2022;65(4):1–6. doi: 10.4103/ijpm.ijpm_1071_21.
   Web of Science ®Google Scholar
• Suman FR, Teja R, Magdalene J, et al. Screening for beta thalassemia carrier state among women attending antenatal clinic in a tertiary care centre and framing a model program for the prevention of beta thalassemia. Cureus. 2022;14(2):e22209. doi: 10.7759/cureus.22209.
   PubMed Web of Science ®Google Scholar
• Wickramaratne KAC, Wijewickrama DC. Screening for beta-thalassemia trait; applicability of red cell indices and parameters—a study in Sri Lanka. Int J Health Sci. 2021;15(1):29–34. PubMed PMID: 33456440; PubMed Central PMCID: PMCPMC7786441.
   Google Scholar
• Cappellini MD, Viprakasit V, Taher AT. An overview of current treatmentstrategies for β-thalassemia. Expert Opin Orphan Drugs. 2014;2(7):665–679. doi: 10.1517/21678707.2014.918503.
   Web of Science ®Google Scholar
• Taher A, Vichinsky E, Musallam K, Cappellini MD, Viprakasit V. Guidelines for the management of non transfusion dependent thalassaemia (NTDT). Weatherall D, editor. Nicosia (Cyprus): Thalassaemia International Federation; 2013.
   Google Scholar
• Matteocci A, Pierelli L. Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing. Vox Sang. 2014;106(3):197–208. doi: 10.1111/vox.12086.
   PubMed Web of Science ®Google Scholar
• ICMR. National estimation of blood requirement in India. New Delhi (India): Ministry of Health and Family Welfare; 2018. p. 1–131.
   Google Scholar
• Rodeghiero F, Ruggeri M. Short- and long-term risks of splenectomy for benign haematological disorders: should we revisit the indications? Br J Haematol. 2012;158(1):16–29. doi: 10.1111/j.1365-2141.2012.09146.x.
   PubMed Web of Science ®Google Scholar
• Tahir F, Ahmed J, Malik F. Post-splenectomy sepsis: a review of the literature. Cureus. 2020;12(2):e6898. doi: 10.7759/cureus.6898.
   PubMed Web of Science ®Google Scholar
• Leone G, Pizzigallo E. Bacterial infections following splenectomy for malignant and nonmalignant hematologic diseases. Mediterr J Hematol Infect Dis. 2015;7(1):e2015057. doi: 10.4084/MJHID.2015.057.
   PubMed Web of Science ®Google Scholar
• Alexakis N, Dardamanis D, Albanopoulos K, et al. Incidence, risk factors, and outcome of portal vein thrombosis after laparoscopic-assisted splenectomy in beta-thalassemia patients: a prospective exploratory study. J Laparoendosc Adv Surg Tech A. 2013;23(2):123–128. doi: 10.1089/lap.2012.0268.
   PubMed Web of Science ®Google Scholar
• Italia KY, Jijina FJ, Merchant R, et al. Response to hydroxyurea in beta thalassemia major and intermedia: experience in western India. Clin Chim Acta. 2009;407(1-2):10–15. doi: 10.1016/j.cca.2009.06.019.
   PubMed Web of Science ®Google Scholar
• Kumar R, Kaur A, Agarwal S. Influence of Xmn 1(G)gamma (HBG2 c.-211 C –> T) Globin gene polymorphism on phenotype of thalassemia patients of North India. Indian J Hematol Blood Transfus. 2014;30(4):286–290. doi: 10.1007/s12288-013-0293-9.
   PubMed Web of Science ®Google Scholar
• Nadkarni A, Gorakshakar AC, Lu CY, et al. Molecular pathogenesis and clinical variability of beta-thalassemia syndromes among Indians. Am J Hematol. 2001;68(2):75–80. doi: 10.1002/ajh.1156.
   PubMed Web of Science ®Google Scholar
• Angelucci E, Matthes-Martin S, Baronciani D, et al. Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel. Haematologica. 2014;99(5):811–820. doi: 10.3324/haematol.2013.099747.
   PubMed Web of Science ®Google Scholar
• Kulkarni U, George B. Access to hematopoietic stem-cell transplantation in India. J Postgrad Med. 2019;65(1):1–4. doi: 10.4103/jpgm.JPGM_391_18.
   PubMed Web of Science ®Google Scholar
• Cunningham MJ, Macklin EA, Neufeld EJ, et al. Complications of beta-thalassemia major in North America. Blood. 2004;104(1):34–39. doi: 10.1182/blood-2003-09-3167.
   PubMed Web of Science ®Google Scholar
• Rashtriya Bal Swasthya Karyakram (RBSK). New Delhi (India): Ministry of Health and Family Welfare; 2013. https://rbsk.gov.in/
   Google Scholar
• Thalassemia Bal Sewa Yojana (TBSY). New Delhi (India): Ministry of Health and Family Welfare; 2017. https://www.coalindia.in/tbsy/
   Google Scholar
• Thiyagarajan A, Bhattacharya S, Sharma N, et al. Need for a universal thalassemia screening programme in India? A public health perspective. J Family Med Prim Care. 2019;8(5):1528–1532. doi: 10.4103/jfmpc.jfmpc_90_19.
   PubMedGoogle Scholar
• Rishmitha , Badagabettu S, Archana MV, et al. Awareness on thalassemia and opinion of carrier screening among young women from selected undergraduate colleges of udupi district. Clin Epidemiol Glob Health. 2022;14:100978. doi: 10.1016/j.cegh.2022.100978.
   Web of Science ®Google Scholar
• Mohammad Sorowar Hossain MMH, Raheem E, Islam MS, et al. Lack of knowledge and misperceptions about thalassaemia among college students in Bangladesh: a cross-sectional baseline study. Orphanet J Rare Dis. 2020;15:1–10.
   PubMed Web of Science ®Google Scholar
• Rao TS, Prabhakar AK, Jagannatha Rao KS, et al. Relationship between consanguinity and depression in a south Indian population. Indian J Psychiatry. 2009;51(1):50–52. doi: 10.4103/0019-5545.44906.
   PubMedGoogle Scholar
• Suresh H, Jamil S, Padhi BK, et al. Thalassemia prevention: religious and cultural barriers to premarital screening in Bangladesh. Health Sci Rep. 2023;6(4):e1176. doi: 10.1002/hsr2.1176.
   PubMedGoogle Scholar
• Ishaq FA, Kokab F, Akhtar A, et al. Awareness among parents of β-thalassemia major patients, regarding prenatal diagnosis and premarital screening. J Coll Physicians Surg Pak. 2012;22:218–221.
   PubMed Web of Science ®Google Scholar
• Akhlaghpoor S. Chorionic villus sampling for beta-thalassemia: the first report of experience in Iran. Prenat Diagn. 2006;26(12):1131–1136. doi: 10.1002/pd.1572.
   PubMed Web of Science ®Google Scholar
• Saxena A, Phadke SR. Feasibility of thalassaemia control by extended family screening in Indian context. J Health Popul Nutr. 2002;20(1):31–35.
   PubMed Web of Science ®Google Scholar